HR2/PasOrl

Status

Available to order

EMMA IDEM:01166
Citation informationRRID:IMSR_EM:01166 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameHR2/PasOrl
Alternative namehairless2-Pasteur
Strain typeSpontaneous
Allele/Transgene symbolHrhr-2Pas
Gene/Transgene symbolHr

Information from provider

ProviderJean-Louis Guénet
Provider affiliationInstitut Pasteur
Genetic informationNot known. Complementation test with another hairless allele.
Phenotypic informationAlopecia.
Breeding historyBred by crossing heterozygous mice together or heterozygous and homozygous mice.
ReferencesNone available

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France

Disease and phenotype information

IMPC phenotypes (gene matching)
  • abnormal coat/ hair morphology / IMPC
  • decreased lymphocyte cell number / IMPC
  • decreased circulating cholesterol level / IMPC
  • increased neutrophil cell number / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • abnormal vibrissa morphology / IMPC
  • decreased circulating amylase level / IMPC
  • absent vibrissae / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
MGI phenotypes (allele matching)
  • abnormal hair growth / MGI
  • hairless / MGI
MGI phenotypes (gene matching)
  • abnormal hair follicle morphology / MGI
  • distended hair follicles / MGI
  • alopecia / MGI
  • sparse hair / MGI
  • short hair / MGI
  • loss of eyelid cilia / MGI
  • abnormal hair cycle / MGI
  • abnormal colon morphology / MGI
  • abnormal intestinal mucosa morphology / MGI
  • deformed nails / MGI
  • long toenails / MGI
  • abnormal hepatocyte morphology / MGI
  • abnormal mammary gland morphology / MGI
  • absent mammary gland / MGI
  • abnormal sebaceous gland morphology / MGI
  • sebaceous gland atrophy / MGI
  • abnormal skin condition / MGI
  • flaky skin / MGI
  • shiny skin / MGI
  • thin skin / MGI
  • thick skin / MGI
  • translucent skin / MGI
  • skin ridges / MGI
  • wrinkled skin / MGI
  • skin lesions / MGI
  • skin hyperplasia / MGI
  • abnormal epidermal layer morphology / MGI
  • thick epidermis / MGI
  • epidermal hyperplasia / MGI
  • abnormal epidermis stratum granulosum morphology / MGI
  • abnormal epidermis stratum corneum morphology / MGI
  • hyperkeratosis / MGI
  • abnormal dermal layer morphology / MGI
  • thick dermal layer / MGI
  • dermal cysts / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • curly vibrissae / MGI
  • wavy vibrissae / MGI
  • loss of vibrissae / MGI
  • short vibrissae / MGI
  • abnormal eyelid morphology / MGI
  • Meibomian gland atrophy / MGI
  • abnormal nursing / MGI
  • abnormal coat appearance / MGI
  • decreased IgM level / MGI
  • abnormal thymus involution / MGI
  • eye inflammation / MGI
  • acanthosis / MGI
  • abnormal lactation / MGI
  • female infertility / MGI
  • increased leukemia incidence / MGI
  • abnormal skin morphology / MGI
  • abnormal hair growth / MGI
  • premature death / MGI
  • abnormal vibrissa morphology / MGI
  • abnormal lymph node secondary follicle morphology / MGI
  • abnormal immunoglobulin level / MGI
  • increased IgG level / MGI
  • granulomatous inflammation / MGI
  • abnormal keratinocyte differentiation / MGI
  • glomerulonephritis / MGI
  • decreased ovulation rate / MGI
  • hair follicle degeneration / MGI
  • epidermal cyst / MGI
  • cochlear ganglion hypoplasia / MGI
  • thymus atrophy / MGI
  • abnormal hair shaft morphology / MGI
  • abnormal hair follicle dermal papilla morphology / MGI
  • hairless / MGI
  • lymph node inflammation / MGI
  • thin hypodermis / MGI
  • decreased cochlear inner hair cell number / MGI
  • decreased cochlear outer hair cell number / MGI
  • absent cochlear hair cell stereocilia / MGI
  • absent linear vestibular evoked potential / MGI
  • decreased thymus weight / MGI
  • decreased T cell number / MGI
  • abnormal dermis reticular layer morphology / MGI
  • decreased T cell proliferation / MGI
  • abnormal Meibomian gland morphology / MGI
  • increased susceptibility to autoimmune disorder / MGI
  • immune system phenotype / MGI
  • hematopoietic system phenotype / MGI
  • loose skin / MGI
  • increased macrophage cell number / MGI
  • thick eyelids / MGI
  • thin retinal ganglion layer / MGI
  • thin retinal inner plexiform layer / MGI
  • abnormal vibrissa number / MGI
  • progressive hair loss / MGI
  • hypergranulosis / MGI
  • epidermis stratum granulosum hyperplasia / MGI
  • enlarged inguinal lymph nodes / MGI
  • enlarged popliteal lymph nodes / MGI
  • abnormal nipple development / MGI
  • abnormal skin appearance / MGI
  • abnormal Meibomian gland acinus morphology / MGI
  • abnormal vibrissa follicle morphology / MGI
  • abnormal skin adnexa physiology / MGI
  • abnormal hair follicle infundibulum morphology / MGI
  • dilated hair follicle infundibulum / MGI
  • abnormal hair follicle outer root sheath morphology / MGI
  • abnormal hair follicle inner root sheath morphology / MGI
  • absent hair follicle dermal papilla / MGI
  • dilated hair follicles / MGI
  • integument phenotype / MGI
  • preweaning lethality, incomplete penetrance / MGI
  • lymph node medullary cord hyperplasia / MGI
  • small sebaceous gland / MGI
  • decreased sebocyte cell number / MGI
  • Meibomian gland cyst / MGI
  • decreased nipple number / MGI
  • thymus cortex atrophy / MGI
  • abnormal eyelid margin morphology / MGI
  • decreased small intestinal villus height / MGI
  • abnormal forehead morphology / MGI
  • abnormal piliary canal morphology / MGI
  • dilated piliary canal / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).